image
Relmada Therapeutics, Inc. RLMD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.5899
4.17 %
$ 19.6 M
Market Cap
-0.25
P/E
Price Target Average
860.61%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
28.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Relmada Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for RLMD of $5.67 , with forecasts ranging from a low of $2 to a high of $8 .
RLMD Lowest Price Target Wall Street Target
2 USD 239.04%
RLMD Average Price Target Wall Street Target
5.67 USD 860.61%
RLMD Highest Price Target Wall Street Target
8 USD 1256.16%
Price
Max Price Target
Min Price Target
Average Price Target
887766554433221100Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26May '26May '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart RLMD

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RLMD

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RLMD

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)20232023202420242025202520262026202720272028202820292029